BENZATHINE PENICILLIN 2.4 M.U PARENTERAL ORDINARY DRY VIALS Uganda - Ingliż - National Drug Authority

benzathine penicillin 2.4 m.u parenteral ordinary dry vials

gittoes pharmaceuticals limited; gittoes pharmaceuticals limited - benzathine penicillin - parenteral ordinary dry vials - 2.4 m.u

Benzathine Benzylpenicillin Injection Kenja - Ingliż - Pharmacy and Poisons Board

benzathine benzylpenicillin injection

benzathine penicillin 2,400,000 iu - injection - 2,400,000 - benzylpenicillin

Bicillin L-A New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

bicillin l-a

pfizer new zealand limited - benzathine benzylpenicillin tetrahydrate 442 mg/ml (1,200,000u/2.3ml) - suspension for injection - 1,200,000 u/2.3 ml - active: benzathine benzylpenicillin tetrahydrate 442 mg/ml (1,200,000u/2.3ml) excipient: carmellose sodium lecithin methyl hydroxybenzoate povidone propyl hydroxybenzoate sodium citrate dihydrate water for injection - intramuscular benzathine benzylpenicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine benzylpenicillin: · streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (eg., pharyngitis). · venereal infections - syphilis, yaws, bejel and pinta.

Pan Benzathine Benzylpenicillin New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pan benzathine benzylpenicillin

pharmacy retailing (nz) ltd t/a healthcare logistics - benzathine benzylpenicillin 900mg - powder for injection - 900 mg - active: benzathine benzylpenicillin 900mg excipient: trisodium citrate monohydrate monosodium citrate trihydrate lecithin polysorbate 80

INTERCLOX DC INTRAMAMMARY SUSPENSION Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

interclox dc intramammary suspension

chem-pharm - cloxacillin, ampicillin - intramammary suspension - base milligrams - beta-lactam antibacterials, penicillins, combinations with other antibacterials - bovine - antibacterial

Bovaclox DC Intramammary Suspension Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

bovaclox dc intramammary suspension

norbrook laboratories limited - cloxacillin; ampicillin - intramammary suspension - 500, 250 mg/syringe - beta-lactam antibacterials, penicillins, combinations with other antibacterials - cattle - antibacterial

BICILLIN L-A- penicillin g benzathine injection, suspension Stati Uniti - Ingliż - NLM (National Library of Medicine)

bicillin l-a- penicillin g benzathine injection, suspension

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 1 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin l-a and other antibacterial drugs, bicillin l-a should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. intramuscular penicillin g benzathine is indicated in the treatment of infections due to penicillin-g-sensitive microorganisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular penicillin g benzathine: mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci. venereal infections —syphilis, yaws, bejel, and pinta. medical conditions in which penicillin g benzathine therapy is indicated as prophylaxis: rheumatic fever and/or chorea —prophylaxis with penicillin g benzathine has proven effective in preventing recurrence of these conditions. it has also been used as follow-up prophylactic therapy for rheumatic heart disease and acute glomerulonephritis. a history of a previous hypersensitivity reaction to any of the penicillins is a contraindication.

BOVACLOX DRY COW New Zealand - Ingliż - Ministry for Primary Industries

bovaclox dry cow

schering-plough animal health limited - ampicillin trihydrate; cloxacillin benzathine - ampicillin trihydrate 55.5 g/litre; cloxacillin benzathine 111.1 g/litre - antibiotic

Dryclox DC AF New Zealand - Ingliż - Ministry for Primary Industries

dryclox dc af

elanco new zealand - cloxacillin benzathine; ampicillin - cloxacillin benzathine 111.1 g/kg; ampicillin 55.55 g/kg - antibiotic

Dryclox Xtra AF New Zealand - Ingliż - Ministry for Primary Industries

dryclox xtra af

elanco new zealand - ampicillin; cloxacillin benzathine - ampicillin 55 g/kg; cloxacillin benzathine 111.1 g/kg - antibiotic